MarketBeat
Bullseye Bounce: Toms Capital Takes a Stake in Target
📈
AI Sentiment
Highly Positive
8/10
- Home
- KVUE
KVUE
Kenvue Inc.
as of 01-05-2026 3:41pm EST
$16.85
$0.43
-2.49%
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.
| Founded: | 2022 | Country: | United States |
| Employees: | N/A | City: | SUMMIT |
| Market Cap: | 33.1B | IPO Year: | 2023 |
| Target Price: | $20.00 | AVG Volume (30 days): | 32.3M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.75 | EPS Growth: | 35.31 |
| 52 Week Low/High: | $14.02 - $25.17 | Next Earning Date: | 02-05-2026 |
| Revenue: | $15,006,000,000 | Revenue Growth: | -2.93% |
| Revenue Growth (this year): | -0.75% | Revenue Growth (next year): | 2.81% |
AI-Powered KVUE Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 78.70%
78.70%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Kenvue Inc. (KVUE)
Smith Jeffrey C
Buy
Director
KVUE Dec 12, 2025
Avg Cost/Share
$17.37
Shares
3,200,000
Total Value
$55,593,600.00
Owned After
27,307,632
SEC Form 4
Smith Jeffrey C
Buy
Director
KVUE Dec 11, 2025
Avg Cost/Share
$17.43
Shares
3,177,694
Total Value
$55,392,926.27
Owned After
27,307,632
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Smith Jeffrey C | KVUE | Director | Dec 12, 2025 | Buy | $17.37 | 3,200,000 | $55,593,600.00 | 27,307,632 | |
| Smith Jeffrey C | KVUE | Director | Dec 11, 2025 | Buy | $17.43 | 3,177,694 | $55,392,926.27 | 27,307,632 |
Latest Kenvue Inc. News
KVUE Breaking Stock News: Dive into KVUE Ticker-Specific Updates for Smart Investing
MarketBeat
Insider Buying: Smart Money Just Spent +$100M on These 3 Stocks
📈
AI Sentiment
Highly Positive
8/10
Barrons.com
Target Stock Needs a Spark. An Activist Investor Could Provide It.
📉
AI Sentiment
Negative
3/10
Compare KVUE vs Leading Stocks
See how KVUE stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "KVUE Kenvue Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.